Grace Therapeutics, Inc. (ACST)
1.93
+0.02
(+0.78%)
USD |
NASDAQ |
Oct 23, 16:00
Grace Therapeutics Price : 1.93 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.91 | 1.95 | 1.88 | 1.93 | 47222.00 |
| Oct 22, 2026 | 1.91 | 1.93 | 1.87 | 1.915 | 97097.00 |
| Oct 21, 2026 | 1.96 | 2.02 | 1.94 | 1.97 | 77141.00 |
| Oct 20, 2026 | 1.90 | 2.07 | 1.89 | 1.98 | 94407.00 |
| Oct 19, 2026 | 1.89 | 1.97 | 1.822 | 1.88 | 90432.00 |
| Oct 16, 2026 | 1.970 | 2.030 | 1.85 | 1.89 | 168796.0 |
| Oct 15, 2026 | 1.91 | 1.97 | 1.89 | 1.95 | 109289.0 |
| Oct 14, 2026 | 1.97 | 2.01 | 1.846 | 1.89 | 177973.0 |
| Oct 13, 2026 | 2.00 | 2.02 | 1.965 | 1.99 | 52406.00 |
| Oct 12, 2026 | 2.02 | 2.06 | 1.98 | 2.02 | 50631.00 |
| Oct 09, 2026 | 2.05 | 2.09 | 2.03 | 2.08 | 37794.00 |
| Oct 08, 2026 | 2.05 | 2.07 | 2.00 | 2.04 | 52592.00 |
| Oct 07, 2026 | 2.06 | 2.12 | 2.05 | 2.10 | 84253.00 |
| Oct 06, 2026 | 2.08 | 2.138 | 2.051 | 2.065 | 110264.0 |
| Oct 05, 2026 | 2.04 | 2.08 | 2.01 | 2.06 | 80043.00 |
| Oct 02, 2026 | 2.04 | 2.07 | 2.00 | 2.07 | 105030.0 |
| Oct 01, 2026 | 2.11 | 2.13 | 1.98 | 2.04 | 344209.0 |
| Sep 30, 2026 | 2.135 | 2.16 | 2.10 | 2.15 | 25340.00 |
| Sep 29, 2026 | 2.11 | 2.15 | 2.089 | 2.11 | 130162.0 |
| Sep 28, 2026 | 2.12 | 2.14 | 2.09 | 2.12 | 58745.00 |
| Sep 25, 2026 | 2.14 | 2.14 | 2.10 | 2.12 | 80177.00 |
| Sep 24, 2026 | 2.17 | 2.18 | 2.09 | 2.16 | 106339.0 |
| Sep 23, 2026 | 2.15 | 2.15 | 2.09 | 2.12 | 193893.0 |
| Sep 22, 2026 | 2.09 | 2.165 | 2.08 | 2.14 | 71117.00 |
| Sep 21, 2026 | 2.12 | 2.150 | 2.08 | 2.10 | 109981.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 285.64 |
| Abeona Therapeutics, Inc. | 4.40 |
| America Great Health | 0.0002 |
| Acumen Pharmaceuticals, Inc. | 1.98 |
| Aardvark Therapeutics, Inc. | 1.39 |
Price Related Metrics
| PEG Ratio | -0.0374 |
| Price to Book Value | 0.6515 |
| Earnings Yield | -61.32% |
| Market Cap | 31.41M |
| PEGY Ratio | -0.0374 |